 |
CHArmacy®
CHArmacy® is an advanced hydroxyapatite calcium filler designed for clinicians and aesthetic seekers who require dependable structural augmentation with natural-looking, long-lasting results. Formulated as a biphasic system combining a high-viscoelastic crosslinked hyaluronic acid matrix and Ventrix Tech™ solid CaHA microbeads, CHArmacy® calcium hydroxyapatite filler delivers immediate volumization and a scaffold for progressive collagen replacement — often producing clinically meaningful aesthetic improvement for two years or longer in many patients.
▪ Two complementary components: a high-viscoelastic crosslinked hyaluronic acid (HA) carrier for immediate tissue integration and viscosity; and ventrix-engineered CaHA microbeads that provide structural support and biostimulation over time.
▪ Ventrix Tech™ microbeads: CHArmacy® uses precisely manufactured, solid Calcium Hydroxylapatite CaHA spheres with a subtly roughened surface topography. This microtexture enhances fibroblast adhesion and matrix deposition while improving the mechanical anchoring of newly formed collagen.
▪ Controlled particle sizing: CaHA microbeads are tightly distributed in the 25–45 μm diameter range with an ultra‑narrow manufacturing tolerance (manufacturing variability < 0.7 μm). Such precision reduces the likelihood of particle migration and supports predictable handling and degradation.
▪ Material mechanics: The CaHA microbeads exhibit a low-porosity structure and an elastic modulus on the order of \~900 Pa, providing a balance between malleability and durable mechanical support.
Ready to elevate your practice or personal treatment results? Discover why more clinics and patients are choosing CHArmacy® hydroxyapatite calcium filler — click here to order now and experience the difference today.
1. Immediate structural correction: On injection, the high-viscoelastic HA network fills volume deficits, smooths creases, and provides instant contour enhancement without displacement.
2. Progressive biological remodeling: Over subsequent months, the HA component is gradually resorbed while the CaHA microbeads persist longer and act as focal points for controlled fibroplasia. The microtextured surfaces encourage fibroblast attachment and new collagen deposition around each bead.
3. Long-term outcome: The new collagen forms a soft, native tissue matrix that replaces the temporary HA carrier as it degrades. Patients commonly experience durable contour restoration that can persist up to two years or longer, depending on individual biology and treatment parameters.
▪ Robust support and shape retention: CaHA microbeads provide a resilient scaffold for tissue augmentation that resists early collapse and preserves contour under mechanical stress.
▪ Biostimulatory effect: The engineered surface topography promotes fibroblast engagement and physiological collagen formation, improving skin quality and tissue thickness adjacent to the treated area.
▪ Predictable performance: Tight particle size control and low-porosity beads reduce variability in clinical behavior and support a favorable tolerability profile.
▪ Immediate patient satisfaction: The HA carrier offers instant, visible improvement at the end of the procedure — an important factor for patient experience.
CHArmacy® hydroxyapatite calcium filler is formulated for aesthetic structural augmentation across multiple facial regions where support and volumization are required, including but not limited to:
Forehead and brow ridges
Nasal architecture
Temporal hollowing
Malar (cheek) and submalar augmentation
Nasolabial folds and marionette lines
Chin contouring and lower‑face shaping
CHArmacy®’s Ventrix Tech™ CaHA microbeads are engineered for biocompatibility and predictable resorption. The controlled particle size distribution and low porosity are designed to minimize local inflammatory responses and reduce the incidence of erythema or hypersensitivity. As with any injectable, adherence to aseptic technique and appropriate patient selection remain essential.
▪ Clinics: benefit from predictable handling and seamless integration into existing treatment protocols. CHArmacy® is engineered for consistent injection performance, reducing downtime and enhancing practitioner confidence. Clinics can rely on a filler that combines immediate aesthetic satisfaction with scientifically supported longevity, ensuring repeat patient visits and strong word‑of‑mouth growth.
▪ Patients: experience instant contour enhancement and smoother facial lines with a soft, natural feel. Over time, as collagen is gradually stimulated, results become even more refined and enduring — often lasting up to two years or more. The blend of immediacy and long‑term rejuvenation inspires patient trust and satisfaction, creating a compelling reason to choose CHArmacy® over conventional fillers.
For further technical specifications, regulatory documentation, or to discuss wholesale pricing and supply logistics, please contact the CHArmacy® sales and clinical support team. We can provide product dossiers and batch data to facilitate clinic evaluation and procurement.
CHArmacy® is an advanced hydroxyapatite calcium filler designed for clinicians and aesthetic seekers who require dependable structural augmentation with natural-looking, long-lasting results. Formulated as a biphasic system combining a high-viscoelastic crosslinked hyaluronic acid matrix and Ventrix Tech™ solid CaHA microbeads, CHArmacy® calcium hydroxyapatite filler delivers immediate volumization and a scaffold for progressive collagen replacement — often producing clinically meaningful aesthetic improvement for two years or longer in many patients.
▪ Two complementary components: a high-viscoelastic crosslinked hyaluronic acid (HA) carrier for immediate tissue integration and viscosity; and ventrix-engineered CaHA microbeads that provide structural support and biostimulation over time.
▪ Ventrix Tech™ microbeads: CHArmacy® uses precisely manufactured, solid Calcium Hydroxylapatite CaHA spheres with a subtly roughened surface topography. This microtexture enhances fibroblast adhesion and matrix deposition while improving the mechanical anchoring of newly formed collagen.
▪ Controlled particle sizing: CaHA microbeads are tightly distributed in the 25–45 μm diameter range with an ultra‑narrow manufacturing tolerance (manufacturing variability < 0.7 μm). Such precision reduces the likelihood of particle migration and supports predictable handling and degradation.
▪ Material mechanics: The CaHA microbeads exhibit a low-porosity structure and an elastic modulus on the order of \~900 Pa, providing a balance between malleability and durable mechanical support.
Ready to elevate your practice or personal treatment results? Discover why more clinics and patients are choosing CHArmacy® hydroxyapatite calcium filler — click here to order now and experience the difference today.
1. Immediate structural correction: On injection, the high-viscoelastic HA network fills volume deficits, smooths creases, and provides instant contour enhancement without displacement.
2. Progressive biological remodeling: Over subsequent months, the HA component is gradually resorbed while the CaHA microbeads persist longer and act as focal points for controlled fibroplasia. The microtextured surfaces encourage fibroblast attachment and new collagen deposition around each bead.
3. Long-term outcome: The new collagen forms a soft, native tissue matrix that replaces the temporary HA carrier as it degrades. Patients commonly experience durable contour restoration that can persist up to two years or longer, depending on individual biology and treatment parameters.
▪ Robust support and shape retention: CaHA microbeads provide a resilient scaffold for tissue augmentation that resists early collapse and preserves contour under mechanical stress.
▪ Biostimulatory effect: The engineered surface topography promotes fibroblast engagement and physiological collagen formation, improving skin quality and tissue thickness adjacent to the treated area.
▪ Predictable performance: Tight particle size control and low-porosity beads reduce variability in clinical behavior and support a favorable tolerability profile.
▪ Immediate patient satisfaction: The HA carrier offers instant, visible improvement at the end of the procedure — an important factor for patient experience.
CHArmacy® hydroxyapatite calcium filler is formulated for aesthetic structural augmentation across multiple facial regions where support and volumization are required, including but not limited to:
Forehead and brow ridges
Nasal architecture
Temporal hollowing
Malar (cheek) and submalar augmentation
Nasolabial folds and marionette lines
Chin contouring and lower‑face shaping
CHArmacy®’s Ventrix Tech™ CaHA microbeads are engineered for biocompatibility and predictable resorption. The controlled particle size distribution and low porosity are designed to minimize local inflammatory responses and reduce the incidence of erythema or hypersensitivity. As with any injectable, adherence to aseptic technique and appropriate patient selection remain essential.
▪ Clinics: benefit from predictable handling and seamless integration into existing treatment protocols. CHArmacy® is engineered for consistent injection performance, reducing downtime and enhancing practitioner confidence. Clinics can rely on a filler that combines immediate aesthetic satisfaction with scientifically supported longevity, ensuring repeat patient visits and strong word‑of‑mouth growth.
▪ Patients: experience instant contour enhancement and smoother facial lines with a soft, natural feel. Over time, as collagen is gradually stimulated, results become even more refined and enduring — often lasting up to two years or more. The blend of immediacy and long‑term rejuvenation inspires patient trust and satisfaction, creating a compelling reason to choose CHArmacy® over conventional fillers.
For further technical specifications, regulatory documentation, or to discuss wholesale pricing and supply logistics, please contact the CHArmacy® sales and clinical support team. We can provide product dossiers and batch data to facilitate clinic evaluation and procurement.
